Subscribe To Our Free Newsletter |
Venus Remedies shares surge 6% on UNICEF tender for Ceftriaxone drug
In its financial results for the quarter ended March 2024, Venus Remedies reported a consolidated net profit of ₹10.51 crore, compared to ₹11.06 crore in the same quarter last year.